Market Research Logo

Biofortuna Ltd - Product Pipeline Analysis, 2017 Update

Summary

Biofortuna Ltd (Biofortuna) is a provider of contract services and molecular diagnostic products. The company distributes CE-marked, freeze-dried PCR diagnostic kits. It has freeze dried molecular diagnostic products targeted at the transplantation, disease identification and pharmacogenetic markets. Biofortuna offers contract development and manufacturing services. It also offers contract IVD development and production services to companies for converting their liquid tests into freeze dried kits, and delivering simple one protocols. The company operates contract manufacturing facilities in the UK. Biofortuna is headquartered in Wirral, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biofortuna Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Biofortuna Ltd Company Overview
Biofortuna Ltd Company Snapshot
Biofortuna Ltd Pipeline Products and Ongoing Clinical Trials Overview
Biofortuna Ltd – Pipeline Analysis Overview
Biofortuna Ltd - Key Facts
Biofortuna Ltd - Major Products and Services
Biofortuna Ltd Pipeline Products by Development Stage
Biofortuna Ltd Pipeline Products Overview
CoaguPlex Genotyping Kit
CoaguPlex Genotyping Kit Product Overview
HemoPlex Kell Genotyping Kit
HemoPlex Kell Genotyping Kit Product Overview
HemoPlex Kidd & Duffy Genotyping Kit
HemoPlex Kidd & Duffy Genotyping Kit Product Overview
HemoPlex MNS Genotyping Kit
HemoPlex MNS Genotyping Kit Product Overview
HemoPlex Multi Blood Group Genotyping Kit
HemoPlex Multi Blood Group Genotyping Kit Product Overview
HemoPlex RHCE Screening Kit
HemoPlex RHCE Screening Kit Product Overview
HemoPlex RHCE Variant Genotyping Kit
HemoPlex RHCE Variant Genotyping Kit Product Overview
HemoPlex RHD & CE Genotyping Kit
HemoPlex RHD & CE Genotyping Kit Product Overview
HemoPlex RHD Screening Kit
HemoPlex RHD Screening Kit Product Overview
HemoPlex RHD Variant Genotyping Kit
HemoPlex RHD Variant Genotyping Kit Product Overview
NeutroPlex HNA Genotyping Kit
NeutroPlex HNA Genotyping Kit Product Overview
ThromboPlex HPA Genotyping Kit
ThromboPlex HPA Genotyping Kit Product Overview
ThromboPlex HPA Screening Kit
ThromboPlex HPA Screening Kit Product Overview
Biofortuna Ltd - Key Competitors
Biofortuna Ltd - Key Employees
Biofortuna Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Biofortuna Ltd, Recent Developments
Jan 24, 2017: Biofortuna expands its immunoassay development and manufacturing services
Oct 03, 2016: Biofortuna Reaches key Milestones for ReadyPlex Blood Group Genotyping product Family
Jul 08, 2016: Biofortuna FDA Inspection Completed Successfully
Jul 27, 2015: Biofortuna launches its new approach to custom IVD manufacture and development services
Feb 24, 2015: Biofortuna appoints new Chairman to lead next phase of growth
Aug 08, 2014: Biofortuna expands its infrastructure and production capacity
Feb 25, 2014: Biofortuna receives FDA clearance of its SSPGo line of HLA molecular diagnostic freeze-dried kits
Mar 18, 2013: Biofortuna announces significant expansion of its infrastructure and head count
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Biofortuna Ltd Pipeline Products and Ongoing Clinical Trials Overview
Biofortuna Ltd Pipeline Products by Equipment Type
Biofortuna Ltd Pipeline Products by Indication
Biofortuna Ltd, Key Facts
Biofortuna Ltd, Major Products and Services
Biofortuna Ltd Number of Pipeline Products by Development Stage
Biofortuna Ltd Pipeline Products Summary by Development Stage
CoaguPlex Genotyping Kit - Product Status
CoaguPlex Genotyping Kit - Product Description
HemoPlex Kell Genotyping Kit - Product Status
HemoPlex Kell Genotyping Kit - Product Description
HemoPlex Kidd & Duffy Genotyping Kit - Product Status
HemoPlex Kidd & Duffy Genotyping Kit - Product Description
HemoPlex MNS Genotyping Kit - Product Status
HemoPlex MNS Genotyping Kit - Product Description
HemoPlex Multi Blood Group Genotyping Kit - Product Status
HemoPlex Multi Blood Group Genotyping Kit - Product Description
HemoPlex RHCE Screening Kit - Product Status
HemoPlex RHCE Screening Kit - Product Description
HemoPlex RHCE Variant Genotyping Kit - Product Status
HemoPlex RHCE Variant Genotyping Kit - Product Description
HemoPlex RHD & CE Genotyping Kit - Product Status
HemoPlex RHD & CE Genotyping Kit - Product Description
HemoPlex RHD Screening Kit - Product Status
HemoPlex RHD Screening Kit - Product Description
HemoPlex RHD Variant Genotyping Kit - Product Status
HemoPlex RHD Variant Genotyping Kit - Product Description
NeutroPlex HNA Genotyping Kit - Product Status
NeutroPlex HNA Genotyping Kit - Product Description
ThromboPlex HPA Genotyping Kit - Product Status
ThromboPlex HPA Genotyping Kit - Product Description
ThromboPlex HPA Screening Kit - Product Status
ThromboPlex HPA Screening Kit - Product Description
Biofortuna Ltd, Key Employees
Glossary
List of Figures
Biofortuna Ltd Pipeline Products by Equipment Type
Biofortuna Ltd Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report